ID   NF1_RAT                 Reviewed;        2820 AA.
AC   P97526;
DT   04-MAY-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   02-OCT-2024, entry version 169.
DE   RecName: Full=Neurofibromin;
DE   AltName: Full=Neurofibromatosis-related protein NF-1;
GN   Name=Nf1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Brain;
RA   Kyritsis A.P., Lee P.S., Mochizuki H., Nishi T., Levin V.A., Saya H.;
RT   "Differential splicing of the neurofibromatosis type 1 (NF1) gene in rats:
RT   homologous splice variants in human are expressed in rat cells.";
RL   Int. J. Oncol. 1:149-152(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Brain;
RX   PubMed=8982875; DOI=10.1093/oxfordjournals.jbchem.a021498;
RA   Suzuki H., Takahashi K., Yasumoto K., Fuse N., Shibahara S.;
RT   "Differential tissue-specific expression of neurofibromin isoform mRNAs in
RT   rat.";
RL   J. Biochem. 120:1048-1054(1996).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-24; 51-63; 78-92; 104-111; 207-218; 249-262; 298-305;
RP   355-366; 462-469; 491-498; 767-785; 792-798; 972-999; 1003-1014; 1179-1209;
RP   1244-1252; 1266-1278; 1293-1327; 1340-1364; 1394-1410; 1426-1438;
RP   1451-1457; 1491-1507; 1550-1556; 1570-1592; 1619-1634; 1707-1726;
RP   1738-1750; 1810-1825; 1830-1851; 1952-1976; 1998-2025; 2132-2150;
RP   2153-2160; 2167-2175; 2206-2228; 2262-2281; 2331-2345; 2468-2498;
RP   2502-2516; 2596-2618 AND 2702-2714, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Pheochromocytoma;
RA   Bienvenut W.V., von Kriegsheim A.F., Kolch W.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-866; SER-2169; SER-2504 AND
RP   SER-2524, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater
CC       affinity for Ras GAP, but lower specific activity. May be a regulator
CC       of Ras activity. {ECO:0000250|UniProtKB:P21359}.
CC   -!- SUBUNIT: Interacts with HTR6. Interacts with SPRED2.
CC       {ECO:0000250|UniProtKB:P21359}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P21359}. Nucleus,
CC       nucleolus {ECO:0000250|UniProtKB:P21359}. Cell membrane
CC       {ECO:0000250|UniProtKB:P21359}.
CC   -!- DOMAIN: Binds phospholipids via its C-terminal CRAL-TRIO domain. Binds
CC       primarily glycerophospholipids with monounsaturated C18:1 and/or C16:1
CC       fatty acid moieties and a phosphatidylethanolamine or
CC       phosphatidylcholine headgroup. Has lesser affinity for lipids
CC       containing phosphatidylserine and phosphatidylinositol.
CC       {ECO:0000250|UniProtKB:P21359}.
CC   -!- PTM: Ubiquitinated by RNF7/RBX2, leading to its degradation.
CC       {ECO:0000250|UniProtKB:Q04690}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D45201; BAA08141.1; -; mRNA.
DR   PIR; JC5196; JC5196.
DR   RefSeq; NP_036741.1; NM_012609.1.
DR   SMR; P97526; -.
DR   BioGRID; 246735; 7.
DR   IntAct; P97526; 4.
DR   MINT; P97526; -.
DR   STRING; 10116.ENSRNOP00000050393; -.
DR   CarbonylDB; P97526; -.
DR   iPTMnet; P97526; -.
DR   PhosphoSitePlus; P97526; -.
DR   PaxDb; 10116-ENSRNOP00000050393; -.
DR   GeneID; 24592; -.
DR   KEGG; rno:24592; -.
DR   AGR; RGD:3168; -.
DR   CTD; 4763; -.
DR   RGD; 3168; Nf1.
DR   eggNOG; KOG1826; Eukaryota.
DR   InParanoid; P97526; -.
DR   OrthoDB; 1356198at2759; -.
DR   PhylomeDB; P97526; -.
DR   Reactome; R-RNO-5658442; Regulation of RAS by GAPs.
DR   ChiTaRS; Nf1; rat.
DR   PRO; PR:P97526; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:HGNC-UCL.
DR   GO; GO:0005737; C:cytoplasm; IDA:HGNC-UCL.
DR   GO; GO:0030425; C:dendrite; IDA:HGNC-UCL.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:HGNC-UCL.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0005096; F:GTPase activator activity; ISS:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:MGI.
DR   GO; GO:0031210; F:phosphatidylcholine binding; ISS:UniProtKB.
DR   GO; GO:0008429; F:phosphatidylethanolamine binding; ISS:UniProtKB.
DR   GO; GO:0045545; F:syndecan binding; IPI:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISS:HGNC-UCL.
DR   GO; GO:0030325; P:adrenal gland development; ISS:HGNC-UCL.
DR   GO; GO:0021764; P:amygdala development; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISO:RGD.
DR   GO; GO:0048844; P:artery morphogenesis; ISS:HGNC-UCL.
DR   GO; GO:0048708; P:astrocyte differentiation; ISO:RGD.
DR   GO; GO:0007420; P:brain development; ISS:HGNC-UCL.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; ISS:HGNC-UCL.
DR   GO; GO:0007154; P:cell communication; ISS:HGNC-UCL.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0034605; P:cellular response to heat; ISO:RGD.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IEP:RGD.
DR   GO; GO:0021987; P:cerebral cortex development; ISS:HGNC-UCL.
DR   GO; GO:0050890; P:cognition; ISO:RGD.
DR   GO; GO:0030199; P:collagen fibril organization; ISS:HGNC-UCL.
DR   GO; GO:0001935; P:endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0030198; P:extracellular matrix organization; ISS:HGNC-UCL.
DR   GO; GO:0097192; P:extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; ISO:RGD.
DR   GO; GO:0048144; P:fibroblast proliferation; ISO:RGD.
DR   GO; GO:0021897; P:forebrain astrocyte development; ISS:HGNC-UCL.
DR   GO; GO:0048853; P:forebrain morphogenesis; ISS:HGNC-UCL.
DR   GO; GO:0061534; P:gamma-aminobutyric acid secretion, neurotransmission; ISO:RGD.
DR   GO; GO:0014009; P:glial cell proliferation; ISO:RGD.
DR   GO; GO:0061535; P:glutamate secretion, neurotransmission; ISO:RGD.
DR   GO; GO:0048820; P:hair follicle maturation; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISS:HGNC-UCL.
DR   GO; GO:0071887; P:leukocyte apoptotic process; ISO:RGD.
DR   GO; GO:0001889; P:liver development; ISS:HGNC-UCL.
DR   GO; GO:0060291; P:long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0000165; P:MAPK cascade; ISS:HGNC-UCL.
DR   GO; GO:0033024; P:mast cell apoptotic process; ISO:RGD.
DR   GO; GO:0070662; P:mast cell proliferation; ISO:RGD.
DR   GO; GO:0001656; P:metanephros development; ISS:HGNC-UCL.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; ISS:HGNC-UCL.
DR   GO; GO:0033028; P:myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:0097529; P:myeloid leukocyte migration; ISO:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0048712; P:negative regulation of astrocyte differentiation; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; ISS:UniProtKB.
DR   GO; GO:0060253; P:negative regulation of glial cell proliferation; ISO:RGD.
DR   GO; GO:0002686; P:negative regulation of leukocyte migration; ISO:RGD.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; ISS:HGNC-UCL.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; ISS:HGNC-UCL.
DR   GO; GO:0070667; P:negative regulation of mast cell proliferation; ISO:RGD.
DR   GO; GO:0007406; P:negative regulation of neuroblast proliferation; ISS:HGNC-UCL.
DR   GO; GO:0046929; P:negative regulation of neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:HGNC-UCL.
DR   GO; GO:0045671; P:negative regulation of osteoclast differentiation; ISO:RGD.
DR   GO; GO:0042308; P:negative regulation of protein import into nucleus; ISO:RGD.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:HGNC-UCL.
DR   GO; GO:0035021; P:negative regulation of Rac protein signal transduction; ISO:RGD.
DR   GO; GO:0046580; P:negative regulation of Ras protein signal transduction; ISO:RGD.
DR   GO; GO:1900148; P:negative regulation of Schwann cell migration; ISO:RGD.
DR   GO; GO:0010626; P:negative regulation of Schwann cell proliferation; ISO:RGD.
DR   GO; GO:2000647; P:negative regulation of stem cell proliferation; ISO:RGD.
DR   GO; GO:1904753; P:negative regulation of vascular associated smooth muscle cell migration; ISO:RGD.
DR   GO; GO:0021915; P:neural tube development; ISO:RGD.
DR   GO; GO:0007405; P:neuroblast proliferation; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0007269; P:neurotransmitter secretion; ISO:RGD.
DR   GO; GO:0098597; P:observational learning; ISO:RGD.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; ISO:RGD.
DR   GO; GO:0001649; P:osteoblast differentiation; ISS:HGNC-UCL.
DR   GO; GO:0030316; P:osteoclast differentiation; ISO:RGD.
DR   GO; GO:0007422; P:peripheral nervous system development; ISS:HGNC-UCL.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISS:HGNC-UCL.
DR   GO; GO:0043473; P:pigmentation; ISS:HGNC-UCL.
DR   GO; GO:0045762; P:positive regulation of adenylate cyclase activity; ISS:HGNC-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:HGNC-UCL.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; ISO:RGD.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISO:RGD.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:2000108; P:positive regulation of leukocyte apoptotic process; ISO:RGD.
DR   GO; GO:0033027; P:positive regulation of mast cell apoptotic process; ISO:RGD.
DR   GO; GO:0033034; P:positive regulation of myeloid cell apoptotic process; ISO:RGD.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISS:HGNC-UCL.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IMP:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0098926; P:postsynaptic signal transduction; IDA:SynGO.
DR   GO; GO:0006606; P:protein import into nucleus; ISO:RGD.
DR   GO; GO:0016601; P:Rac protein signal transduction; ISO:RGD.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISS:HGNC-UCL.
DR   GO; GO:0045765; P:regulation of angiogenesis; ISS:HGNC-UCL.
DR   GO; GO:0043535; P:regulation of blood vessel endothelial cell migration; ISO:RGD.
DR   GO; GO:0045124; P:regulation of bone resorption; ISS:HGNC-UCL.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0001952; P:regulation of cell-matrix adhesion; ISS:HGNC-UCL.
DR   GO; GO:0070372; P:regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0045685; P:regulation of glial cell differentiation; ISS:HGNC-UCL.
DR   GO; GO:0043087; P:regulation of GTPase activity; IMP:HGNC-UCL.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; ISO:RGD.
DR   GO; GO:1900271; P:regulation of long-term synaptic potentiation; ISO:RGD.
DR   GO; GO:0043408; P:regulation of MAPK cascade; ISO:RGD.
DR   GO; GO:0099159; P:regulation of modification of postsynaptic structure; IDA:SynGO.
DR   GO; GO:0045664; P:regulation of neuron differentiation; IMP:RGD.
DR   GO; GO:0099175; P:regulation of postsynapse organization; ISO:RGD.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; ISS:HGNC-UCL.
DR   GO; GO:0014044; P:Schwann cell development; ISS:HGNC-UCL.
DR   GO; GO:0014037; P:Schwann cell differentiation; IEP:RGD.
DR   GO; GO:0036135; P:Schwann cell migration; ISO:RGD.
DR   GO; GO:0014010; P:Schwann cell proliferation; ISO:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; ISO:RGD.
DR   GO; GO:0048745; P:smooth muscle tissue development; ISS:HGNC-UCL.
DR   GO; GO:0021510; P:spinal cord development; ISS:HGNC-UCL.
DR   GO; GO:0072089; P:stem cell proliferation; ISO:RGD.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISS:HGNC-UCL.
DR   GO; GO:1904738; P:vascular associated smooth muscle cell migration; ISO:RGD.
DR   GO; GO:1990874; P:vascular associated smooth muscle cell proliferation; ISO:RGD.
DR   GO; GO:0008542; P:visual learning; ISS:HGNC-UCL.
DR   GO; GO:0042060; P:wound healing; ISS:HGNC-UCL.
DR   CDD; cd13313; PH_NF1; 1.
DR   CDD; cd05130; RasGAP_Neurofibromin; 1.
DR   CDD; cd00170; SEC14; 1.
DR   Gene3D; 3.40.525.10; CRAL-TRIO lipid binding domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR001251; CRAL-TRIO_dom.
DR   InterPro; IPR036865; CRAL-TRIO_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR054071; PH_NF1.
DR   InterPro; IPR039360; Ras_GTPase.
DR   InterPro; IPR023152; RasGAP_CS.
DR   InterPro; IPR001936; RasGAP_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   PANTHER; PTHR10194:SF142; NEUROFIBROMIN; 1.
DR   PANTHER; PTHR10194; RAS GTPASE-ACTIVATING PROTEINS; 1.
DR   Pfam; PF13716; CRAL_TRIO_2; 1.
DR   Pfam; PF21877; PH_NF1; 1.
DR   Pfam; PF00616; RasGAP; 1.
DR   SMART; SM00323; RasGAP; 1.
DR   SMART; SM00516; SEC14; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF48350; GTPase activation domain, GAP; 1.
DR   PROSITE; PS50191; CRAL_TRIO; 1.
DR   PROSITE; PS00509; RAS_GTPASE_ACTIV_1; 1.
DR   PROSITE; PS50018; RAS_GTPASE_ACTIV_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Cell membrane; Direct protein sequencing; GTPase activation;
KW   Lipid-binding; Membrane; Nucleus; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.3"
FT   CHAIN           2..2820
FT                   /note="Neurofibromin"
FT                   /id="PRO_0000056667"
FT   DOMAIN          1237..1432
FT                   /note="Ras-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00167"
FT   DOMAIN          1561..1719
FT                   /note="CRAL-TRIO"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00056"
FT   REGION          1561..1818
FT                   /note="Lipid binding"
FT                   /evidence="ECO:0000250"
FT   REGION          2457..2482
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2768..2820
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           2536..2552
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        2783..2812
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.3"
FT   MOD_RES         866
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         878
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P21359"
FT   MOD_RES         2169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2448
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q04690"
FT   MOD_RES         2495
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q04690"
FT   MOD_RES         2496
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P21359"
FT   MOD_RES         2502
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P21359"
FT   MOD_RES         2504
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2524
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2546
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P21359"
FT   MOD_RES         2578
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P21359"
FT   MOD_RES         2783
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P21359"
FT   MOD_RES         2798
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P21359"
SQ   SEQUENCE   2820 AA;  317083 MW;  FC108487E86DA89F CRC64;
     MAAHRPVEWV QAVVSRFDEQ LPIKTGQQNT HTKVSTEHNK ECLINISKYK FSLVISGLTT
     ILKNVNNMRI FGEAAEKNLY LSQLIILDTL EKCLAGQPKD TMRLDETMLV KQLLPEICHF
     LHTCREGNQH AAELRNSASG VLFSLSCNNF NAVFSRISTR LQELTVCSED NVDVHDIELL
     QYINVDCAKL KRLLKETAFK FKALKKVAQL AVINSLEKAF WNWVENYPDE FTKLYQIPQT
     DMAECAGKLF DLVDGFAEST KRKAAVWPLQ IILLILCPEI IQDISRDVVD ENNTNKKLFL
     DSLRKALAGH GGSRQLTESA AIACVKLCKA STYINWEDNS VIFLLVQSMV VDLKNLLFNP
     SKPFSRGSQP ADVDLMIDCL VSCFRISPHN NQHFKICLAQ NSPSTFHYVL VNSLHRIITN
     SAWDWWPKID AVYCHSVELR NMFGETLHKA VQGCGAHPAL RMAPSLTFKE KVTSLKFKEK
     PTDLEARSYK YLLLSMVKLI HADPKLLLCN PRKQGPETQG STAELITGLV QLVPQSHMPE
     VAQEAMEALL VLHQLDSIDL WNPDAPVETF WEISSQMLFY ICKKLTSHQM LSSTEILKWL
     REILICRNKF LLKNKQADRS SCHSLYLYGV GCDLPASGNV TQMSVDHEES LRTCAPGASL
     RKGRGNSSMD STAGCSGTPP ICRQAQTKLE VALYMFLWSP DTEVVLVAMS CFRHLCEEAD
     IRCGVDEVSV HNFLPNYNTF MEFASVSNML STGRAALQKR VMALLRRIEH PTAGNTEAWE
     DTHAKWEQAT KLILNYPKAK MEDGQAAESL HKTIVKRRMS HVSGGGSIDL SDTDSLQEWI
     NMTGFLCALG GVCLQQRSSS GLATYSPPMG PVSERKGSMI SVMSSEGNVD SPVSRFMDRL
     LSLMVCNHEK VGLQIRTNVK DLVGLELSPA LYPMLFNKLK SAISKFFDSQ GQVLLTDSNT
     QFVEQTIAIM KNLLDNHTEG SSEHLGQASI ETMMLNLVRY VRVLGNMVHA IQIKTKLCQL
     VEVMMARRDD LSFCQEMKFR NKMVEYLTDW VMGTSNQAAD DDVKCLTRDL DQASMEAVVS
     LLAGLPLQPE EGDGVELMEA KSQLFLKYFT LFMNLLNDCS EVEDENAQTG GRKRGMSRRL
     ASLRHCTVLA MSNLLNANVD SGLMHSIGLG YHKDLQTRAT FMEVLTKILQ QGTEFDTLAE
     TVLADRFERL VELVTMMGDQ GELPIAMALA NVVPCSQWDE LARVLVTLFD SRHLLYQLLW
     NMFSKEVELA DSMQTLFRGN SLASKIMTFC FKVYGATYLQ KLLDPLLRII ITSSDWQHVS
     FEVDPTRLEP SESLEENQRN LLQMTEKFFH AIISSSSEFP SQLRSVCHCL YQVVSQRFPQ
     NSIGAVGSAM FLRFINPAIV SPYEAGILDK KPPPRIERGL KLMSKVLQSI ANHVLFTKEE
     HMRPFNDFVK SNFDLARRFF LDIASDCPTS DAVNHSLSFI SDGNVLALHR LLWNNQEKIG
     QYLSSNRDHK AVGRRPFDKM ATLLAYLGPP EHKPVADTHW SSLNLTSSKF EEFMTRHQVH
     EKEEFKALKT LSIFYQAGTS KAGNPIFYYV ARRFKTGQIN GDLLIYHVLL TLKPYYAKPY
     EIVVDLTHTG PSNRFKTDFL SKWFVVFPGF AYDNVSAVYI YNCNSWVREY TKYHERLLTG
     LKGSKRLIFI DCPGKLAEHI EHEQQKLPAA TLALEEDLKV FHNALKLAHK DTKVSIKVGS
     TAVQVTSAER TKVLGQSVFL NDIYYASEIE EICLVDENQF TLTIANQGTP LTFMHQECEA
     IVQSIIHIRT RWELSQPDSI PQHTKIRPKD VPGTLLNIAL LNLGSSDPSL RSAAYNLLCA
     LTCTFNLKIE GQLLETSGLC IPANNTLFIV SISKTLAANE PHLTLEFLEE CISGFSKSSI
     ELKHLCLEYM TPWLSNLVRF CKHNDDAKRQ RVTAILDKLI TMTINEKQMY PSIQAKIWGS
     LGQITDLLDV VLDSFIKTSA TGGLGSIKAE VMADTAVALA SGNVKLVSSK VIGRMCKIID
     KTCLSPTPTL EQHLMWDDIA ILARYMLMLS FNNSLDVAAH LPYLFHVVTF LVATGPLSLR
     ASTHGLVINI IHSLCTCSQL HFSEETKQVL RLSLTEFSLP KFYLLFGISK VKSAAVIAFR
     SSYRDRSFSP GSYERETFAL TSLETVTEAL LEIMEACMRD IPTCKWLDQW TELAQRFAFQ
     YNPSLQPRAL VVFGCISKRV SHGQIKQIIR ILSKALESCL KGPDTYNSQV LIEATVIALT
     KLQPLLNKDS PLHKALFWVA VAVLQLDEVN LYSAGTALLE QNLHTLDSLR IFNDKSPEEV
     FMAIRNPLEW HCKQMDHFVG LNFNSNFNFA LVGHLLKGYR HPSPAIVART VRILHTLLTL
     VNKHRNCDKF EVNTQSVAYL AALLTVSEEV RSRCSLKHRK SLLLTDISME NVPMDTYPIH
     HGDPSSRTLK ETQPWSSPRG SEGYLAATYP AVGQTSPRAR KSMSLDMGQP SQANTKKLLG
     TRKSFDHLIS DTKAPKRQEM ESGITTPPKM RRVAETDYEM ETQRISSSQQ HPHLRKVSVS
     ESNVLLDEEV LTDPKIQALL LTVLATLVKY TTDEFDQRIL YEYLAEASVV FPKVFPLVHN
     LLDSKINTLL SLCQDPNLLN PIHGIVQSVV YHEESPPQYQ TSYLQSFGFN GLWRFAGPFS
     KQTQIPDYAE LIVKFLDALI DTYLPGIDEE TSEESLLTPT SPYPPALQSQ LSITANLNLS
     NSMTSLATSQ HSPGIDKENV ELSPTTGHCN SGRTRHGSAS QVQKQRSAGS FKRNSIKKIV
//
